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Prevalence of Toxoplasmic Retinochoroiditis
in an Australian Adult Population
A Community-Based Study
Lisia B. Ferreira, MD,1,* João M. Furtado, MD, PhD,2,* Jason Charng, PhD,3 Maria Franchina, PhD,3
Janet M. Matthews, BS(Hons),1 Aus A.L. Molan, PhD,5,6 Michael Hunter, PhD,4
David A. Mackey, FRANZCO, MD,3,y Justine R. Smith, FRANZCO, PhD1,7,y
Purpose: Toxoplasmic retinochoroiditis is the most common clinical manifestation of an infection with the
protozoan parasite, Toxoplasma gondii. Up to 50% of the human population is estimated to be infected with
T. gondii; however, the epidemiology of toxoplasmic retinochoroiditis has not been widely reported. We sought to
estimate the prevalence of toxoplasmic retinochoroiditis in Australia using data that were collected as part of the
Busselton Healthy Ageing Study.
Design: Cross-sectional, community-based, prospective cohort study.
Participants: 5020 Australian adults (2264 men and 2756 women; age range, 45e69 years, and median age,
58 years).
Methods: Retinal color photographs, centered on the optic disc and macula, were captured using a digital
retinal camera after the dilation of the pupils. Three uveitis-subspecialized ophthalmologists assessed each
pigmented retinal lesion, and complete concordance of opinion was required to assign a toxoplasmic etiology.
Serum T. gondii immunoglobulin (Ig)G levels were measured for those participants with retinal lesions judged to
be toxoplasmic retinochoroiditis.
Main Outcome Measures: Prevalence of toxoplasmic retinochoroiditis.
Results: Eight participants (0.16%) had retinal lesions that were considered to have the characteristic
appearance of toxoplasmic retinochoroiditis, plus detectable serum T. gondii IgG, consistent with the diagnosis of
toxoplasmic retinochoroiditis. On the assumption that 23.81% of retinal lesions occur at the posterior pole, as
reported in a community-based survey conducted in Brazil (Sci Rep. 2021;11:3420), the prevalence of toxoplasmic
retinochoroiditis was estimated to be 0.67% or 1 per 149 persons.
Conclusions: Toxoplasmic retinochoroiditis is common in Australian adults. Efforts to quantify and address
risk factors for human infection with T. gondii are justiﬁed. Ophthalmology Retina 2022;6:963-968 ª 2022 by the
American Academy of Ophthalmology. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).

Toxoplasma gondii is an Apicomplexan protozoan parasite
that causes the infectious disease known as toxoplasmosis.1
Globally, a wide spectrum of mammals and birds are
infected with T. gondii, which is contracted in
environments soiled by primary feline hosts or by
consuming the carcasses of other infected animals.2
Humans, in particular, develop toxoplasmosis most
commonly after eating undercooked meat sourced from
infected livestock.3 Manifestations of the disease depend
on the age, health, and genetics of the infected individual
and the parasite strain, load, and form, as well as
environmental factors.4 The most common clinical
manifestation is a recurrent, unilateral, inﬂammatory
retinal diseasedor posterior uveitisdtermed ocular
toxoplasmosis or, more speciﬁcally, toxoplasmic
retinochoroiditis.5,6 Cohort studies have demonstrated that
 2022 by the American Academy of Ophthalmology. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Published by Elsevier Inc.

approximately 60% of inﬂamed eyes develop reduced
vision, and up to 25% become irreversibly blind.7e9 On
resolution of an attack of inﬂammation, the individual is left
with a pigmented retinal scar that has a highly typical
clinical appearance.10
It has been widely stated that between 30% and 50% of
the human population is infected with T. gondii.11 This
estimate is based on the prevalence of antieT. gondii
immunoglobulin (Ig) in the serum, and studies from
around the world have provided seroprevalence rates that
range widely from 0.5% to 87.7%, with regional
differences.12 Arguably, the more important statistic is the
prevalence of the clinical disease, but there have been no
national population-based and few community-based
observational studies of toxoplasmic retinochoroiditis with
serologic conﬁrmation of T. gondii infection.1 A major
https://doi.org/10.1016/j.oret.2022.04.022
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challenge in studying the epidemiology of this condition is
that, unless an individual experiences an attack of
inﬂammation, they are unlikely to present for medical
care. Moreover, screening for the disease requires
pharmacologic dilation of the pupils and examination of
the retina, which are not routine procedures outside an
ophthalmology clinic.
In the study reported here, we sought to address the
epidemiologic knowledge gap in toxoplasmic retinochoroiditis by using data that were collected as part of the
Busselton Healthy Ageing Study.13 Retinal color
photographs from approximately 5000 individuals living
in urban Western Australia were obtained during this
project to evaluate the prevalence of glaucoma and agerelated macular degeneration. Three uveitis-subspecialized
ophthalmologists reviewed these photographs, and serum
was tested for T. gondii IgG to provide an estimate of the
prevalence of toxoplasmic retinochoroiditis in an Australian
cohort.

Methods
This study made use of clinical data that were collected in the
course of the Busselton Healthy Ageing Study. The design and
methods of this study have been previously described in detail.13
In summary, this is a community-based, prospective cohort study
involving 5107 “baby boomers” (ie, individuals born between
1946 and 1964) who resided within the local government electoral
boundary of the City of Busselton in Western Australia. All
persons listed on the compulsory Western Australian Electoral
Commission Electoral Roll were eligible to participate; 82% of
those on the electoral register were contacted and conﬁrmed
eligible, and 76% of those contacted were recruited between May
2010 and December 2015. The overall goal of the project is “to
identify the cumulative effects of disparate illnesses that constitute
the burden of disease that impacts on healthy ageing.”13 Baseline
data collection included a health- and lifestyle-focused questionnaire, blood sampling, anthropometric measurements and body
imaging, cardiovascular and respiratory monitoring, tests of
physical function and balance, cognitive assessment, sleep studies,
and auditory and ophthalmic examinations.
The ophthalmic assessment included retinal color photography,
with the stated purpose of assessment for glaucoma and age-related
macular degeneration. Unless they declined, the participants had
dilation of the pupil of each eye with 1% tropicamide eye drops.
Between 15 and 20 minutes later, retinal photographs were taken
using a digital retinal camera (Canon CR-1). Two images were
obtained, one centered on the optic disc and the other centered on
the macula. These images were saved in JPG format with 300
pixels/inch resolution of a 15.84  10.56 inch2 photograph. Retinal
images were available for 5020 participants. These images were
screened to identify the participants with pigmented retinal lesions
in 1 or both eyes.
The diagnosis of toxoplasmic retinochoroiditis was based
primarily on the clinical appearance of the retinal lesion, which is
standard practice.14,15 Three uveitis-subspecialized ophthalmologists (L.B.F., J.M.F., J.R.S.) assessed each pigmented retinal
lesion during a virtual conference chaired by a fourth ophthalmologist (D.M.) (Zoom Video Conferencing).16 As noted by
Stanford et al,16 the intraclass correlation coefﬁcient for
diagnosis of toxoplasmic retinochoroiditis from retinal
photographs by experts is moderate to good, and complete
concordance of opinion was required to establish the diagnosis.
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Given the high infection rate with T. gondii in the human
population, a negative T. gondii serologic test is used to
exclude the diagnosis.14,15 Thus, for participants who had
retinal lesions that were judged to be toxoplasmic
retinochoroiditis, serum T. gondii IgG levels were measured at
PathWest Laboratory Medicine WA (Nedlands, Australia),
using the Alinity i Toxo IgG Reagent Kit, which is a
chemiluminescent
microparticle
immunoassay
(Abbott
Laboratories).
The Busselton Healthy Ageing Study is approved by the University of Western Australia Human Research Ethics
Committee (approval number RA/4/1/2203). The study adheres to
the Declaration of Helsinki, and all study participants have provided written informed consent. The use of retinal photographs
from the Busselton Healthy Ageing Study for the purpose of this
work speciﬁcally was approved by the Busselton Population
Medical Research Institute Scientiﬁc Committee (approval number
BSN20/02). A literature search conducted using the National Library of Medicine, National Center for Biotechnology Information
PubMed database with multiple search terms (ie, population AND
ocular toxoplasmosis; population AND toxoplasmic retinochoroiditis; community AND ocular toxoplasmosis; community AND
toxoplasmic retinochoroiditis; epidemiology AND toxoplasmic
retinochoroiditis; epidemiology AND ocular toxoplasmosis, last
updated on April 11, 2022) identiﬁed no national population-based
studies of the epidemiology of serologically conﬁrmed ocular
toxoplasmosis.

Results
A total of 5020 participants in the Busselton Healthy Ageing Study
(2264 men and 2756 women, aged 45 to 69 years, with a median
age of 58 years) provided retinal color photographs. Among this
group of adults, 4909 (97.8%) were meat eaters, including 4808
(95.8%) who ate red meat, and 963 (19.2%) were cat owners.
Overall, 306 participants had pigmented retinal lesions around the
macula or optic nerve. Twelve participants (0.24%) had retinal
lesions that were judged by all 3 uveitis-subspecialized ophthalmologists to have the characteristic appearance of toxoplasmic
retinochoroiditis. Serum tested from 8 of these 12 participants
(0.16%) returned a positive result for T. gondii IgG, indicating the
diagnosis of toxoplasmic retinochoroiditis. Retinal photographs
from these 8 participants are presented in Figure 1; given that the
retinal photographs were obtained for the purpose of visualizing
the macula or optic nerve, in several of the images, the lesions
are located at the edge of the ﬁeld of photography.
Toxoplasmic retinochoroiditis may occur at any location across
the retina, although there is a tendency for the lesions to occur in
the central retina (ie, in the region of the macula and optic disc). A
recent community-based survey conducted in Cássia dos
Coqueiros, São Paulo, Brazil (721 adult participants), used our
deﬁnition of toxoplasmic retinochoroiditis and described the disease by location across the retina, distinguishing “central” and
“peripheral” lesions located within and outside the posterior pole,
respectively; the work showed that toxoplasmic retinal lesions
were located in the central retina in 23.81% of affected individuals.17 By applying this ﬁgure to our ﬁndings from the
photographs centered on the macula and on the optic disc, the
prevalence of toxoplasmic retinochoroiditis at any location across
the retina may be estimated at 0.67% of the Busselton Healthy
Ageing Study population or 1 per 149 persons.
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Prevalence of Toxoplasmic Retinochoroiditis in Australia

Figure 1. Color photographs of the retina from participants of the Busselton Health Ageing Study, who were diagnosed with toxoplasmic
retinochoroiditis on the basis of clinical appearance and serum Toxoplasma gondii immunoglobulin G. Images were centered on the optic disc (AeC, H) or
macula (DeG), and for some images (A, D, H), the lesions are located at the edge of the photographic ﬁeld.
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Discussion
Despite the high rates of T. gondii infection in human and
diverse animal populations across the world, the prevalence
of the clinical disease remains poorly described. The most
common manifestation of the infection is toxoplasmic retinochoroiditis, but because toxoplasmosis is a neglected
disease, it is difﬁcult to gain traction for dedicated studies to
describe its epidemiology. To estimate the prevalence of
toxoplasmic retinochoroiditis, we applied standard diagnostic methods to retinal photographs based at the macula
and at the optic disc that were collected as part of an
Australian community-based health survey with independent goals. We drew from a smaller community-based study
conducted in Brazil that involved retinal examinations, with
assessments of both the posterior pole and periphery17;
although parasite strains differ between these countries,
this factor is not known to inﬂuence the location of
lesions. We found that toxoplasmic retinochoroiditis was
common in Australian adultsdapproximately 1 in 150
adults suffers from this conditiondbased on a population
of baby boomers aged 45 to 69 years at the time of the
retinal photography. The rate of T. gondii infection
increases with age,18 and thus, the prevalence is expected
to be lower than this ﬁgure in children and younger adults
and higher than this ﬁgure in older adults.
There have been no national population-based studies of
the epidemiology of serologically conﬁrmed ocular toxoplasmosis, but community-based surveys have been conducted in the Americas and Africa. An early survey,
undertaken in Erechim, Rio Grande do Sul, alerted the ﬁeld
to a potentially high prevalence of the disease in Brazil,19
and several surveys have been conducted in different
regions of the country over the past 2 decades. Applying
the same criteria that we employed to identify toxoplasmic
retinochoroiditis, De Amorim Garcia et al20 described a
prevalence of 0.94% in 959 students studying in Natal,
Rio Grande do Norte, in 2001; Aleixo et al21 reported a
prevalence of 3.8% in 1071 residents of Santa Rita de
Cássia, Rio de Janeiro, in 2004; and De Angelis et al17
measured a prevalence of 5.8% in 721 adults living in
Cássia dos Coqueiros, São Paulo, in 2016 and 2017.
Surveys in 2005 of 200 staff and students at the
University of Quindío, Colombia, and in 2013 of 390
children and adults across households in the Central
Region, Ghana, indicated a prevalence of toxoplasmic
retinochoroiditis by clinical and serologic markers of 4.5%
and 2.6%, respectively.22,23
This work represents the ﬁrst effort to quantify the rate of
ocular toxoplasmosis in the Western Paciﬁc Region of the
world. The prevalence of toxoplasmic retinochoroiditis that
we have estimated is lower than those reported in the South
American and West African surveys. Although it may be
relevant that our study included a considerably higher
number of participants than any of the other surveys,
regional environmental factors are likely to inﬂuence the
prevalence of the condition. Interestingly, in 2003,
Holland24 predicted the prevalence of toxoplasmic
retinochoroiditis in the United States to be 2% of the
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infected population, which most recently was measured at
11.14% of persons aged over 5 years18; his prediction
suggests a prevalence that is also lower than the
previously reported ﬁgures and, indeed, is lower than our
result in the Busselton community cohort.
A summary of serologic studies conducted at antenatal
clinics and blood banks across Australia, published in 1979,
suggested that 24% to 44% of the population was infected with
T. gondii.25 The treatment of drinking water by ﬁltration and
regulated farming and food processing in Australia are likely
to reduce the risk of contamination of food with T. gondii.
On the other hand, Australia has substantial feral cat
populations that are highly infected,26 which, together with
the high levels of free-range and organic livestock farming,
may promote infection with the parasite. We recently detected
frequent contamination of Australian lamb with T. gondii.3
There is a vogue for eating a wide range of meats
undercooked or raw, which overall is considered the most
common route for becoming infected,27 and over 95% of the
study group were meat eaters. Parasite genetics may also
affect the likelihood of developing ocular toxoplasmosis,
although review of 19 parasite genotyping studies in patients
with ocular toxoplasmosis shows that strains across all
genotypes may cause toxoplasmic retinochoroiditis.1 There
have been several reports of T. gondii genotypes in
Australia, each involving the study of a small number of
animals, including 12 kangaroos and bettongs, 16 kangaroos
and wallaroos, 8 wombats, and 8 domestic cats.28e31 The
study of macropods was conducted in the state of Western
Australia, approximately 450 miles from Busselton.29 These
studies showed marked genotypic diversity across the
strains, with a majority having nonarchetypal clonal or
atypical genetics.
As applies to all clinical research on toxoplasmic retinochoroiditis, not only epidemiologic studies, one limitation
of our work relates to diagnostic accuracy. It is not possible to
recover an organism to conﬁrm the diagnosis, given that
T. gondii resides in the retina and retinal biopsy is inherently
damaging to the intraocular tissues. Polymerase chain reaction ampliﬁcation of parasite DNA in ocular ﬂuid is used
clinically,32 but only in ambiguous cases because there is risk
to the sampling procedure,33 and not in epidemiologic
studies. Thus, the diagnostic standard is the clinical
appearancedwhich was judged by 3 uveitis-subspecialized
ophthalmologists in this studydalong with positive
T. gondii serology.15 Negative serology is possible in patients
with
ocular
toxoplasmosis,
speciﬁcally
in
immunocompromised or aged persons.34,35 Like other
investigators, we observed lesions that were typical of
toxoplasmic retinochoroiditis but had to be discounted
because serology was negative. Recently reported
diagnostic criteria apply to active disease only14 and must
be modiﬁed for epidemiologic surveys, in which most or
all toxoplasmic lesions are expected to be inactive. Another
limitation of our work relates to the ocular imaging; with
the advent of wide-ﬁeld photography and nonmydriatic
cameras,36 there exists the opportunity for a broader retinal
coverage and increased participation in future studies in
this area.

Ferreira et al
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In summary, this work represents the ﬁrst effort to estimate the prevalence of toxoplasmic retinochoroiditis in an
Australian population. Our ﬁndings indicate that this condition is common. Furthermore, these results imply that

efforts to quantify and address risk factors are justiﬁed,
including infections in domesticated and feral cats,
contamination of meat, and preparation of meat and meat
products for human consumption.
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